学部概况
教师队伍
人才培养
学院、部
临床医院
科学研究
管理服务
交流合作
北医产业
ENGLISH
 
 
 
 招生就业
 招聘信息
 校园文化
 服务平台
 校内信息
 信息周刊
首页 >> 学术讲座 >>

(10月13日)北京大学基础医学院院长论坛
发布日期:2016-10-10 浏览次数: 字号:[ ]

  报告题目:Tumour heterogeneity, cellular plasticity and single cell sequencing

  报告人:Xin Lu, Ph.D.

          Professor and Director, Ludwig Institute for Cancer Research

          Oxford University, UK

          Elected Member, European Molecular Biology Organization

          Elected Fellow, the Academy of Medical Sciences

  时    间:2016年10月13日(星期四)上午10:30

  地    点:医学部生化楼三层中厅

  主持人:尹玉新院长

  

  报告人简介:

  Professor Lu’s group has long standing research interests in tumour suppression. She was one of the first researchers to show that the tumour suppressor p53 responds to both oncogene activation and DNA damaging signals. Her group was one of the first to demonstrate how to selectively activate p53 to kill cancer cells, through identification and characterization of the evolutionarily conserved ASPP family of proteins.

  报告内容简介:

  Tumour heterogeneity underlies differences in cancer progression and responses to therapy and is caused by genetic and cellular heterogeneity. Cellular heterogeneity is itself caused by cellular plasticity. Over 80% of human tumours originate from epithelial cells and these cells have the unique property of cell polarity, which acts as a first line of defence against infection and a barrier against cancer cell invasion. In this session we will discuss how epithelial cell plasticity is controlled by molecular switches operating at levels from cell polarity and cell adhesion that senses external signals such as infection to gene regulation by transcription factors and cell fate determination. We will also illustrate how single cell sequencing technology can enable us to study cellular heterogeneity in vivo in human tissues.




打印本页 关闭窗口

版权所有:北京大学医学部 北京市海淀区学院路38号  邮编:100191  京ICP备05065075号-19